Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease

被引：0
|
作者：
F. Nicoletti
I. Conget
M. Di Mauro
R. Di Marco
M. Mazzarino
K. Bendtzen
A. Messina
R. Gomis
机构：
[1] Department of Biomedical Sciences,
[2] University of Catania,undefined
[3] Italy,undefined
[4] Endocrinology and Diabetes Unit,undefined
[5] Hospital Clinic,undefined
[6] Faculty of Medicine,undefined
[7] University of Barcelona,undefined
[8] IDIBAPS,undefined
[9] Barcelona,undefined
[10] Spain,undefined
[11] Department of Microbiological and Gynaecological Sciences,undefined
[12] University of Catania,undefined
[13] Catania,undefined
[14] Italy,undefined
[15] Institute for Inflammation Research,undefined
[16] Rigshospitalet University Hospital,undefined
[17] Copenhagen,undefined
[18] Denmark,undefined
[19] Department of Biomedical Sciences,undefined
[20] Section of General Pathology,undefined
[21] University of Catania,undefined
[22] Via Luigi Sturzo n.3,undefined
[23] 95021,undefined
[24] Cannizzaro,undefined
[25] Aci-Castello,undefined
[26] Catania,undefined
[27] Italy,undefined
来源：
Diabetologia | 2002年 / 45卷
关键词：
Autoimmunity chemokines cytokines interferon-gamma IP-10/CXCL10;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Abstract
引用
收藏
页码：1107 / 1110
页数：3
相关论文
共 10 条
  • [1] Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease
    Nicoletti, F
    Conget, I
    Di Mauro, M
    Di Marco, R
    Mazzarino, MC
    Bendtzen, K
    Messina, A
    Gomis, R
    [J]. DIABETOLOGIA, 2002, 45 (08) : 1107 - 1110
  • [2] to:: !Nicoletti F, !Conget L, !DiMauro M et al. (2002) -: Serum concentrations of the interferon-α-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type 1 diabetes mellitus patients and subjects at risk of developing the disease.
    Rotondi, M
    Romagnani, P
    Brozzetti, A
    Santeusanio, F
    Serio, M
    Falorni, A
    [J]. DIABETOLOGIA, 2003, 46 (07) : 1020 - 1021
  • [3] —to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-α-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107–1110
    M. Rotondi
    P. Romagnani
    A. Brozzetti
    F. Santeusanio
    M. Serio
    A. Falorni
    [J]. Diabetologia, 2003, 46 : 1020 - 1021
  • [4] Interferon-β induces transient systemic IP-10/CXCL10 chemokine release in patients with multiple sclerosis
    Buttmann, M
    Merzyn, C
    Rieckmann, P
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 156 (1-2) : 195 - 203
  • [5] Serum levels of the interferon-γ-inducible a chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy
    Antonelli, A.
    Fallahi, P.
    Rotondi, M.
    Ferrari, S. M.
    Serio, M.
    Miccoli, P.
    [J]. BRITISH JOURNAL OF SURGERY, 2006, 93 (10) : 1226 - 1231
  • [6] Increase of interferon-γ-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy
    Antonelli, A
    Rotondi, M
    Fallahi, P
    Romagnani, P
    Ferrari, SM
    Barani, L
    Ferrannini, E
    Serio, M
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 64 (02) : 189 - 195
  • [7] Iodine-131 given for therapeutic purposes modulates differently interferon-γ-inducible α-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter
    Antonelli, Alessandro
    Rotondi, Mario
    Fallahi, Poupak
    Grosso, Mariano
    Boni, Giuseppe
    Ferrari, Silvia Martina
    Romagnani, Paola
    Serio, Mario
    Mariani, Giuliano
    Ferrannini, Ele
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1485 - 1490
  • [8] Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed Type 1 diabetes: a longitudinal study
    Antonelli, A.
    Fallahi, P.
    Ferrari, S. M.
    Pupilli, C.
    d'Annunzio, G.
    Lorini, R.
    Vanelli, M.
    Ferrannini, E.
    [J]. DIABETIC MEDICINE, 2008, 25 (11) : 1349 - 1353
  • [9] Correlation of Type I Interferon Score and CXCL10 (C-X-C Motif Chemokine Ligand 10) with Cutaneous and Muscular Disease Activity in Juvenile Dermatomyositis Patients
    Nicolai, Rebecca
    Moneta, Gian Marco
    Caiello, Ivan
    Marafon, Denise Pires
    Rosina, Silvia
    Laudiero, Luisa Bracci
    Ravelli, Angelo
    De Benedetti, Fabrizio
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] Activated T lymphocytes from patients with high risk of type I diabetes mellitus have different ability to produce interferon-γ, interleukin-6 and interleukin-10 and undergo anti-CD95 induced apoptosis after insulin stimulation
    Tchórzewski, H
    Glowacka, E
    Banasik, M
    Lewkowicz, P
    Szalapska-Zawodniak, M
    [J]. IMMUNOLOGY LETTERS, 2001, 75 (03) : 225 - 234
1